Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2019

Feb 8, 2019

34129_dirs_2019-02-08_97032a17-e7b6-44e5-bf4c-13aa36fce88e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2019-02-06

Reporting Person: Fust Matthew K (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-06 Common Stock M 6924 $20.15 Acquired 7424 Direct
2019-02-06 Common Stock S 6924 $29.38 Disposed 500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-06 Stock Option (right to buy) $20.15 M 6924 Disposed 2024-06-05 Common Stock (6924.0) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2018.

F2: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $29.23 to $29.73. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.